[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-oravacs":3},{"head":4,"company":39,"invest":44,"children":45,"shops":46,"category":47,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":20,"pagekeywords":21,"pagedesc":22,"brandContent":23,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":35,"enterWebsite":36,"business":37,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"43489","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002F3d57546b1fd0fb5723c30726606d406f.gif","可唯适OraVacs","oravacs",37051,8602,"400-820-8389","1995年","上海市",275,0,"1","上海联合赛尔生物工程有限公司",[],"可唯适医药品牌简介_可唯适制药怎么样→品牌之家","可唯适医药,可唯适药品,可唯适注射剂,可唯适疫苗,可唯适肠溶胶囊,可唯适生长激素","可唯适药业品牌简介，品牌之家为您推荐可唯适药品品牌历程、产品价格、口碑评价等内容。","上海联合赛尔生物工程有限公司（简称：上海联合赛尔 Shanghai United Cell Biotechnology Co.， Ltd.）成立于1995年，由联合制药集团创立，现主要投资者为高瓴资本。上海联合赛尔是集基因重组生物制品和疫苗的研究开发、制造及销售为一体的产业化基地，位于上海自由贸易试验区的生物技术园，公司占地2万平方米，建筑面积24000平方米。拥有年产1276万支冻干粉针剂，1300万支卡式瓶水针和1000万粒胶囊及400万袋颗粒剂的生产线。\n\n随着生物制药领域的产品增多、业务扩大、生产线增加，上海联合赛尔于2015年在中国珠海高新技术产业开发区参与投资成立珠海联合赛尔生物工程有限公司，厂区位于珠海高新区科技创新海岸。上海联合赛尔将利用过去20年建立的强大跨国营销体系，实现中国生物工程产品国际化的目标，为中国生物工程产业走向世界提供机遇和资源。","中国（上海）自由贸易试验区桂桥路1150号","9131000060733826XF","有限责任公司(港澳台法人独资)","韦勇夫","1995-12-28","自由贸易试验区市场监管局","1995-12-28 至 2045-12-27","2024-04-12","6,115万(美元)","5,947.7379万(美元)","药物的研发、生产，销售自产产品，并提供相关的技术咨询和售后服务；提供医药市场信息服务，采用生物工程技术的新型药物生产、生物工程领域内的技术开发（人体干细胞、基因诊断与治疗技术的开发和应用除外）、技术服务，技术咨询，自有研发成果的转让。【依法须经批准的项目，经相关部门批准后方可开展经营活动】","021-50318800","www.unitedbiotech.com.cn","研究和试验发展","xiaochen.cai@sucb.sh.cn",{"enterId":40,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":35,"enterWebsite":36,"business":37,"performance":41,"socialSecurity":42,"registrationNumber":43,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"37051","开业","388人","310115400034271",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[48],{"createTime":49,"updateTime":50,"createBy":5,"updateBy":5,"industryId":51,"webId":5,"industryName":52,"industryAlias":5,"industryIcon":5,"industryTrans":53,"pageTitle":54,"pageDesc":55,"pageKeywords":56,"mainTitle":57,"pageSubtitle":58,"indSummary":59,"industryLevel":60,"parentId":61,"parentName":5,"sortOrder":62,"status":16,"classifyVisit":5,"totalVisits":63,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-16 16:50:00","8602","疫苗","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002Fc5a4873d1129759bfb754af8c30ad9d2.png","十大大型疫苗公司排行榜-人用疫苗公司有哪些-ZGALL品牌榜","2026年疫苗行业十大品牌权威发布！疫苗排行榜前十名品牌有中国生物、默沙东、辉瑞、葛兰素史克、赛诺菲、智飞生物、沃森、万泰疫苗、康泰、华兰。疫苗10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解大型疫苗公司有哪些品牌。","大型疫苗公司有哪些,大型疫苗公司排名,疫苗种类有几种厂家,中国人用疫苗企业有多少,大型疫苗公司排名前十","疫苗品牌排行榜","2026人用疫苗企业排行，大型疫苗公司排行榜，疫苗厂家有哪些","疫苗什么牌子好？品牌TOP榜权威发布2026年疫苗十大品牌名录；居前十的有：中国生物CNBG、MSD默沙东、pfizer辉瑞、GSK葛兰素史克、赛诺菲巴斯德、智飞生物ZFSW、沃森生物WALVAX、万泰疫苗INNOVAX、康泰生物、华兰疫苗等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,99,395]